{"sourcedb":"DevicePMAs@therightstef","sourceid":"P890014_S002","text":"Approval for a change in the Enzyme tracer and Tracer Diluent from a IgG (sheep) anti-HAV-HRP to a Fab anti-HAV (Mab)-HRP; a chang ein the Positive Control material to a human source sera; the elimination of the mercury preservative in the reagents; a change in the incubation times from an overnight procedure to a four and one-half hour incubation; the addition of an indicator dye; and the addition of a Calibrator reagent.  The device, as modified, will be marketed under the trade name DiaSorin ETI-HA-IGMK PLUS and is intended for use in the qualitative determination of IgM antibodies to hepatitis A virus (IgM anti-HAV) in human serum or plasma.  This assay is indicated for use as an aid in the diagnosis and monitoring of acute or recent hepatitis A virus infection.","project":"consensus_PMA_Age_Indications"}